{"transactions":[{"id":739308,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":38593,"kind":"person","name":"Jenkins Abigail L.","position":1,"cik":"0001947032","reported_name":"Jenkins Abigail L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-06-12T15:42:54.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":false,"shares":50500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 10, 2027, subject to Ms. Jenkins' continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":50500,"derivative":{"exercise_price":3.99,"exercise_date":"2027-06-10","expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":50500},"source":{"system":"sec-edgar","filing":"0001214659-26-007397","document":"marketforms-73383.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465926007397/marketforms-73383.xml","form_type":"4"}},{"id":1112969,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":38593,"kind":"person","name":"Jenkins Abigail L.","position":1,"cik":"0001947032","reported_name":"Jenkins Abigail L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-06-12T17:59:05.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":false,"shares":42000,"price":3.41,"value":143220.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 11, 2026, subject to Ms. Jenkins' continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":42000,"derivative":{"exercise_price":3.41,"exercise_date":"2026-06-11","expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001214659-25-009121","document":"marketforms-69481.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925009121/marketforms-69481.xml","form_type":"4"}},{"id":1518826,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":38593,"kind":"person","name":"Jenkins Abigail L.","position":1,"cik":"0001947032","reported_name":"Jenkins Abigail L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-05-13T17:40:07.000Z","date":"2024-05-10","kind":"grant","planned":false,"acquired":false,"shares":57000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three equal annual installments beginning on May 10, 2025."}],"balance_after":57000,"derivative":{"exercise_price":3.09,"expiration_date":"2034-05-10","underlying":"Common Stock","underlying_shares":57000},"source":{"system":"sec-edgar","filing":"0001214659-24-008873","document":"marketforms-65565.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465924008873/marketforms-65565.xml","form_type":"4"}},{"id":1756808,"issuer":{"id":94655,"kind":"organization","name":"Gamida Cell Ltd.","symbol":"GMDA"},"owners":[{"id":38593,"kind":"person","name":"Jenkins Abigail L.","position":1,"cik":"0001947032","reported_name":"Jenkins Abigail L.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2023-10-20T16:40:48.000Z","date":"2023-10-19","kind":"grant","planned":false,"acquired":true,"shares":217954,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"The option grant was approved by the Board of Directors of the Issuer on February 8, 2023, subject to shareholder approval. The Issuer's shareholders approved the grant at the annual general meeting of the shareholders on October 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"33% of the shares subject to the option award vested or shall vest on each of August 8, 2023 and August 8, 2024, respectively, and 34% of the shares subject to the option award shall vest on August 8, 2025, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":217954,"derivative":{"exercise_price":1.59,"expiration_date":"2033-10-18","underlying":"Ordinary Shares","underlying_shares":217954},"source":{"system":"sec-edgar","filing":"0001209191-23-053269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1600847/000120919123053269/doc4.xml","form_type":"4"}},{"id":1756807,"issuer":{"id":94655,"kind":"organization","name":"Gamida Cell Ltd.","symbol":"GMDA"},"owners":[{"id":38593,"kind":"person","name":"Jenkins Abigail L.","position":1,"cik":"0001947032","reported_name":"Jenkins Abigail L.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2023-10-20T16:40:48.000Z","date":"2023-10-19","kind":"grant","planned":false,"acquired":true,"shares":109013,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The restricted stock unit (\"RSU\") award was approved by the Board of Directors of the Issuer on February 8, 2023, subject to shareholder approval. The Issuer's shareholders approved the award at the annual general meeting of the shareholders on October 19, 2023."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents an RSU award, which vested or shall vest with respect to 33% of the RSUs, on each of August 8, 2023 and August 8, 2024, respectively, and with respect to 34% of the RSUs, on August 8, 2025. The vesting of the RSUs is subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":375142,"source":{"system":"sec-edgar","filing":"0001209191-23-053269","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600847/000120919123053269/doc4.xml","form_type":"4"}},{"id":1756801,"issuer":{"id":94655,"kind":"organization","name":"Gamida Cell Ltd.","symbol":"GMDA"},"owners":[{"id":38593,"kind":"person","name":"Jenkins Abigail L.","position":1,"cik":"0001947032","reported_name":"Jenkins Abigail L.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2023-10-20T16:34:06.000Z","date":"2023-10-19","kind":"grant","planned":false,"acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"The option grant was approved by the Board of Directors of the Issuer on September 19, 2022, subject to shareholder approval. The Issuer's shareholders approved the grant at the annual general meeting of the shareholders on October 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One fourth (1/4th) of the shares subject to the option award vested on September 19, 2023, and one twelfth (1/12th) of the remaining shares subject to the option award vested or shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":1000000,"derivative":{"exercise_price":2.22,"expiration_date":"2033-10-18","underlying":"Ordinary Shares","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001209191-23-053258","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1600847/000120919123053258/doc4a.xml","form_type":"4/A","original_submission_date":"2022-09-20"}},{"id":1756800,"issuer":{"id":94655,"kind":"organization","name":"Gamida Cell Ltd.","symbol":"GMDA"},"owners":[{"id":38593,"kind":"person","name":"Jenkins Abigail L.","position":1,"cik":"0001947032","reported_name":"Jenkins Abigail L.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2023-10-20T16:34:06.000Z","date":"2023-10-19","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The restricted stock unit (\"RSU\") award was approved by the Board of Directors of the Issuer on September 19, 2022, subject to shareholder approval. The Issuer's shareholders approved the award at the annual general meeting of the shareholders on October 19, 2023."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents an RSU award, which vested or shall vest with respect to 33% of the RSUs, on each of September 19, 2023 and September 19, 2024, respectively, and with respect to 34% of the RSUs, on September 19, 2025. The vesting of the RSUs is subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":266129,"source":{"system":"sec-edgar","filing":"0001209191-23-053258","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600847/000120919123053258/doc4a.xml","form_type":"4/A","original_submission_date":"2022-09-20"}},{"id":2143633,"issuer":{"id":94655,"kind":"organization","name":"Gamida Cell Ltd.","symbol":"GMDA"},"owners":[{"id":38593,"kind":"person","name":"Jenkins Abigail L.","position":1,"cik":"0001947032","reported_name":"Jenkins Abigail L.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-10-04T16:19:28.000Z","date":"2022-09-30","kind":"purchase","acquired":true,"shares":16129,"price":1.55,"value":24999.95,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person purchased ordinary shares of the Issuer at a price of $1.55 per share in an underwritten public offering by the Issuer, which closed on September 30, 2022."}],"balance_after":266129,"source":{"system":"sec-edgar","filing":"0001209191-22-052218","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600847/000120919122052218/doc4.xml","form_type":"4"}},{"id":2153878,"issuer":{"id":94655,"kind":"organization","name":"Gamida Cell Ltd.","symbol":"GMDA"},"owners":[{"id":38593,"kind":"person","name":"Jenkins Abigail L.","position":1,"cik":"0001947032","reported_name":"Jenkins Abigail L.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-20T16:10:35.000Z","date":"2022-09-19","kind":"grant","acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One fourth (1/4th) of the shares subject to the option award shall vest on September 19, 2023, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":1000000,"derivative":{"exercise_price":2.22,"expiration_date":"2032-09-18","underlying":"Ordinary Shares","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001209191-22-050708","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1600847/000120919122050708/doc4.xml","form_type":"4"}},{"id":2153877,"issuer":{"id":94655,"kind":"organization","name":"Gamida Cell Ltd.","symbol":"GMDA"},"owners":[{"id":38593,"kind":"person","name":"Jenkins Abigail L.","position":1,"cik":"0001947032","reported_name":"Jenkins Abigail L.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-09-20T16:10:35.000Z","date":"2022-09-19","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award, which shall vest with respect to 33% of the RSUs, on each of September 19, 2023 and September 19, 2024, respectively, and with respect to 34% of the RSUs, on September 19, 2025. The vesting of the RSUs is subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":250000,"source":{"system":"sec-edgar","filing":"0001209191-22-050708","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600847/000120919122050708/doc4.xml","form_type":"4"}}]}